Zusammenfassung
In den Tabellen sind die in Deutschland (D), Österreich (A) und der Schweiz (CH) im Handel erhältlichen Tranquilizer und Hypnotika alphabetisch nach ihren gebräuchlichen Kurzbezeichnungen aufgeführt. Es wurden die in der Roten Liste 1994 angegebenen internationalen Freinamen (INN), INNv (vorgeschlagene internationale Freinamen) oder sonstige Kurzbezeichnungen gewählt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adams K, Oswald I (1986) The hypnotic effects of an antihistamine: promethazine. Br J Clin Pharmacol 22: 715–717
Alford C, Rombaut N, Jones J, Foley S et al. (1992) Acute effects of hydroxyzine on nocturnal sleep and sleep tendency the following day: a C-EEG study. Hum Psychopharmacol 7: 25–35
Ameer B, Greenblatt DJ (1981) Lorazepam: a review of its clinical pharmacological properties and therapeutic uses. Drugs 21: 161–200
Angelini G, Bichisao E, Catapano F et al. (1989) Ketazolam, a new long-acting benzodiazepine, in the treatment of anxious patients. A multicenter study of 2056 patients. Curr Ther Res 45: 294–304
Ansseau M, VON Frenckell R (1990/91) Controlled comparison of two anxiolytic benzodiazepines, cloxazolam and bromazepam. Neuropsychobiology 24: 25–29
Aubin HJ, Goldenberg F, Benoit O, Gillet C et al. (1994) Effects of tetrabamate and of diazepam on sleep polygraphy during subacute withdrawal in alcohol-dependent patients. Hum Psychopharmacol 9: 191–195
Ayd FJ (1964) Perphenazine: a reappraisal after eight years. Dis Nerv Syst 25: 311–317
Balderer G, Borbely A (1985) Effect of valerian on human sleep. Psychopharmacology 87: 406–409
Bareggi SR, Nielsen NP, Leva S et al. (1986) Age-related multiple-dose pharmacokinetics and anxiolytic effects of delorazepam (chlordesmethyldiazepam). Int J Clin Pharmacol Res 6: 309–314
Baskin SI, Esdale A (1982) Is chlordiazepoxide the rational choice among benzodiazepines? Pharmacotherapy 2: 110–119
Borbely AA, Youmbi-Balderer G (1988) Effect of diphenhydramine on subjective sleep parameters and on motor activity during bedtime. Clin Pharmacol Ther Toxicol 26: 392–396
Breimer DD (1977) Clinical pharmacokinetics of hypnotics. Clin Pharmacokinet 2: 93–109
Brenner HD, Alberti L, Keller F, Schaffner L (1984) Pharmacotherapy of agitational states in psychiatric gerontology: double blind study: febarbamate-pipamperone. Neuropsy-chobiology 11: 187–190
Brogden RN, Goa KL (1991) Flumazenil: a reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonist. Drugs 42: 1061–1089
Brogden RN, Heel RC, Speight TM et al. (1980) Clobazam: a review of its pharmacological properties and therapeutic use in anxiety. Drugs 20: 161–178
Chambaud P, Cochet E, Coppon M et al. (1986) Clotiazepam dans le traitement de l’anxiete en psychiatrie. Sem Hop 62: 969–972
Clark BG, Jue SG, Dawson GW, Ward A (1986) Loprazolam: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in insomnia. Drugs 31: 500–516
Dawson GW, Jue SG, Brogden RN (1984) Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression. Drugs 27: 132–147
Dehlin O (1986) Hypnotic effect of chlormethiazole in geriatric patients during longterm treatment. Acta Psychiatr Scand 73 [Suppl 329]: 112–115
Demisch L, Hölzlj, Gollnik B, Kaczmarik P (1989) Identification of selective MAO-type-A inhibitors in hypericum perforatum (Hyperforat registered). Pharmacopsychiatry 22: 194
Dencker SJ, Fasth BG (1986) Combination of psychotherapy and drugs in the treatment of neurosis. A controlled comparison of bromazepam and thioridazine. Acta Psychiatr Scand 74: 569–575
Dorman T (1983) A multi-centre comparison of prazepam and diazepam in the treatment of anxiety. Pharmatherapeutica 3: 433–440
Dundee JW, Halliday NJ, Harper KW et al. (1984) Midazolam: a review of its pharmacological properties and therapeutic use. Drugs 28: 519–543
Eison AS, Temple DL (1986) Buspirone: review of its pharmacology and current perspectives on its mechanism of action. Am J Med 80: 1–9
Ellenbroek B, Prinssen A, Cools A (1992) The azaphenothiazine prothipendyl is an atypical neuroleptic acting through dopamine D-l and D-2 receptors. Neurosci Res Commun 11:155–161
Farrell K (1986) Benzodiazepines in the treatment of children with epilepsy. Epilepsy 27 [Suppl 1]: 45–51
Fawcett JA, Kravitz HM (1982) Alprazolam: pharmacokinetics, clinical efficacy, and mechanism of action. Pharmacotherapy 2: 243–254
Felger HL (1971) Chlorprothixene-enforced sleep for newly admitted patients with acute mental decompensation. Dis Nerv Syst 32: 46–51
Ferrillo F, Balestra V, Carta F et al. (1984) Comparison between the central effects of camazepam and temazepam. Computerized analysis of sleep recordings. Neuropsychobiology 11: 72–76
Fontaine R, Chouinard G, Annable L (1984) Bromazepam and diazepam in generalized anxiety: a placebo-controlled study of efficacy and withdrawal. Psychopharmacol Bull 20: 126–127
Fuillade P, Pringuey D, Belugou JL et al. (1992) Trimipramine: acute and lasting effects on sleep in healthy and major depressive subjects. J Affect Disord 24: 135–146
Gallagher BB, Baumel IP, Mattson RH et al. (1973) Primidone, diphenylhydantoin and phenobarbital. Aspects of acute and chronic toxicity. Neurology 23: 145–149
Gerster G, Gracza L (1990) Piper methysticum. therapeutikon 4: 257–266
Goa KL, Heel RC (1986) Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic. Drugs 32: 48–65
Goa KL, Ward A (1986) Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 32: 114–129
Graham SR, Day RO, Lee R et al. (1988) Overdose with chloral hydrate: pharmacologie and therapeutic review. Med J Aust 149: 686–688
Greenblatt DJ, Shader RI, Abernethy DR (1983) Current status of benzodiazepines. N Engl J Med 309: 354–358, 410-415
Heel RC, Brogden RN, Speight TM et al. (1981) Temazepam: a review of its pharmacologial properties and therapeutic efficacy as an hypnotic. Drugs 21: 321–340
Helmchen H, Hippius H, Tölle R (Hrsg) (1988) Therapie mit Neuroleptika-Perazin. Thieme, Stuttgart
Hill RC, Harry TVA (1983) Lormetazepam (Lora-met registered): a multicentre assessment of its efficacy and acceptability as a hypnotic in outpatients with sleep disturbances. J Int Med Res 11: 325–332
Hindmarch I, Musch B (eds) (1990) Zopiclone in clinical practice. CNS, London
Hoehns JD, Perry PJ (1993) Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia. Clin Pharm 12: 814–828
Holmberg G, Livstedt B (1972) Clinical evaluation of a new benzodiazepine derivate, chlorazepate. Arzneimittelforschung 22: 916–919
Hölzl J (1993) Inhaltsstoffe und Wirkmechanismen des Johanniskrautes. Z Phytother 14: 255–258, 261-264
Huybrechts I (1991 ) The pharmacology of alprazolam: a review. Clin Ther 13: 100–117
Janiri L, Agnes M, Ciaramella A (1987) Low-dose fluphenazine and detoxification-induced anxiety in opiate addicts. Curr Ther Res Clin Exp 41: 516–524
Kales A, Bixler EO, Soldatos CR et al. (1982) Dose-response studies of lormetazepam: efficacy, side effects, and rebound insomnia. J Clin Pharmacol 22: 520–530
Kangas L, Breimer DD (1981) Clinical pharmacokinetics of nitrazepam. Clin Pharmacokinet 6: 346–366
Kanto J, Kangas L, Leppanen T (1982) A comparative study of the clinical effects of oral flunitrazepam, medazepam, and placebo. Int J Clin Pharmacol Ther Toxicol 20: 431–433
Karlsson E, Larsson LE, Nilsson K (1993) The effects of prophylactic dixyrazine on postoperative vomiting after two different anaesthetic methods for squint surgery in children. Acta Anaesthesiol Scand 37: 45–48
Keane PE, Simiand J, Morre M, Biziere K (1988) Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities I. Psychopharmacological profile in rodents. J Pharmacol Exp Ther 245: 692–698
Kragh-Sorensen P, Holm P, Fynboe C et al. (1990) Bromazepam in generalized anxiety. Randomized, multi-practice comparisons with both chlorprothixene and placebo. Psychopharmacology 100: 383–386
Krieglstein J, Grusla D (1988) Zentral dämpfende Inhaltsstoffe im Baldrian. Dtsch Apotheker Z 128: 2041–2046
Laakmann G, Blaschke D, Hippius H, Schewe S (1989) Double-blind study of metaclazepam versus diazepam treatment of outpatients with anxiety syndrome. Pharmacopsychiatry 22: 120–125
Lader MH, Curry S, Baker WJ (1980) Physiological and psychological effects of clorazepate in man. Br J Clin Pharmacol 9: 83–90
Langley MS, Clissold SP (1988) Brotizolam: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an hypnotic. Drugs 35: 104–122
Langtry HD, Benfield P (1990) Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 40: 291–313
Lapierre YD (1989) A review of trimipramine. 30 years of clinical use. Drugs 38 [Suppl 1]:17–24
Lauven PM, Kulka PJ (1990) Anaesthesia techniques for midazolam and flumazenil: an overview. Acta Anaesthesiol Scand 34: 84–89
Lehmann E, Hassel P, Thorner GW, Karrass W (1984) Alternatives Therapiekonzept zur Behandlung psychosomatischer Beschwerden. Kontrollierte Doppelblind-Prüfung von Fluspirilen versus Bromazepam. Fortschr Med 102: 1033–1036
Levander S, Hagermark O, Stahle M (1985) Peripheral antihistamine and central sedative effects of three Hl-receptor antagonists. Eur J Clin Pharmacol 28: 523–529
Mattila MAK, Larni HM (1980) Flunitrazepam: a review of its pharmacological properties and therapeutic use. Drugs 20: 353–374
Mcalpine CJ, Ankier SI, Elliott CS (1984) A multicentre hospital study to compare the hypnotic efficacy of loprazolam and nitrazepam. J Int Med Res 12: 229–237
Mendels J, Krajewski TF, Huffer V et al. (1986) Effective short-term treatment of generalized anxiety disorder with trifluoperazine. J Clin Psychiatry 47: 170–174
Meriguet C, Sztern A (1990) Nordazepam, anxiety treatment. Psychol Med 22: 1397–1404
Miller LG, Greenblatt DJ, Abernethy DR, Friedman H et al. (1988) Kinetics, brain uptake, and receptor binding characteristics of flurazepam and its metabolites. Psychopharmacology 94:386–391
Napoliello MJ, Domantay AG (1991) Buspirone: a worldwide update. Br J Psychiatry 12 [Suppl]: 40–44
Nelson E, Powell JR, Conrad K et al. (1982) Phenobarbital pharmacokinetics and bioavailability in adults. J Clin Pharmacol 22: 141–148
Neuhaust (1976) BP 400-ein neues Sedativum für die pädiatrische Praxis. Praxis 65: 1603–1610
Orzack MH, Friedman L, Dessain E, Bird M et al. (1988) Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo. Int J Addict 23: 449–467
Osterheider M (1990) Flupentixoldecanoat und Fluspirilen im Vergleich. Münch Med Wochenschr 132 [Suppl]: 10–12
Ott G (1984) Chronische Bromintoxikation. Nervenheilkunde 3: 162–167
Pakes GE, Brogden R, Heel R et al. (1981) Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs 22: 81–110
Pathy MSJ, Bayer AJ, Stoker MJ (1986) A doubleblind comparison of chlormethiazole and temazepam in elderly patients with sleep distur bances. Acta Psychiatr Scand 73 [Suppl 329]:99–103
Piccione P, Zorick F, Lutz T et al. (1980) The efficacy of triazolam and chloral hydrate in geriatric insomniacs. J Int Med Res 8: 361–367
Pinder RM, Brogden RN, Sawyer PR, Speight TM et al. (1976) Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry. Drugs 12: 1–40
Pöldinger W (1984) Melperone in low doses in anxious neurotic patients. A double blind placebo-controlled clinical study. Neuropsy-chobiology 11: 181–186
Pollack MH (1987) Clonazepam: a review of open clinical trials. J Clin Psychiatry 48 [Suppl]:12–14
Reves JG, Fragen RJ, Vinik HR et al. (1985) Midazolam: pharmacology and use. Anesthesiology 62: 310–324
Rickels K, Ginsberg J, Morris RJ et al. (1984) Doxylamine succinate in insomniac family practice patients: a double-blind study. Curr Ther Res 35: 532–540
Rickels K, Morris RJ, Mauriello R et al. (1986) Brotizolam, a triazolothienodiazepine, in insomnia. Clin Pharmacol Ther 40: 293–299
Roache JD, Griffiths RR (1987) Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability. J Pharmacol Exp Ther 243: 978–988
Roth T, Roehrs T, Koshorek G et al. (1987) Sedative effects of antihistamines. J Allerg Clin Immunol 60: 94–98
Ruhland M (1985) Metaclazepam-a new anxiolytic benzodiazepine with selective tolerance and cross tolerance to other benzodiazepines. Pharmacopsychiatry 18: 22–23
Saletu B, Kindshofer G, Anderer P, Grünberger J (1987) Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise. Int J Clin Pharmacol Res 7: 407–418
Saletu B, Grünberger J, Linzmayer L, Anderer P (1989) EEG-brain mapping, psychometric and psychophysiological studies on central effects of kavain-a kava plant derivative. Hum Psy-chopharmacol 4: 169–190
Salzman C, Shader RI, Greenblatt DJ et al. (1983) Long v short half-life benzodiazepines in the elderly. Kinetics and clinical effects of diazepam and oxazepam. Arch Gen Psychiatry 40: 293–297
Shaw DL, Page JA (1960) A three year review of the pharmacologie properties and clinical performance of promazine. Curr Ther Res 2: 199–226
Simonoff EA, Stores G (1987) Controlled trial of trimeprazine tartrate for night waking. Arch Dis Child 62: 253–257
Simons KJ, Watson WT, Chen XY et al. (1989) Pharmacokinetic and pharmacodynamic studies of the HI-receptor antagonist hydroxyzine in the elderly. Clin Pharmacol Ther 45: 9–14
Sjoqvist F, Lasagna L (1967) The hypnotic efficacy of doxylamine. Clin Pharmacol Ther 8:48–54
Stotsky B (1984) Multicenter study comparing thioridazine with diazepam and placebo in elderly, nonpsychotic patients with emotional and behavioral disorders. Clin Ther 6: 546–559
Tegeler, J Lehmann E, Weiher A, Heinrich K (1990) Safety of long-term neuroleptanxiolysis with fluspirilene 1.5 mg per week. Pharmacopsychiatry 23: 259–264
Wadworth AN, Mctavish D (1993) Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs Aging 3: 441–459
Wendt G, Binz U, Müller AA (1985) Opipramol bei Angst und Schlafstörungen-eine Alternative zu Tranquilizern. Med Welt 36: 506–512
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Wien
About this chapter
Cite this chapter
Dietmaier, O., Laux, G. (1995). Übersichtstabellen. In: Riederer, P., Laux, G., Pöldinger, W. (eds) Neuro-Psychopharmaka Ein Therapie-Handbuch. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6593-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6593-5_8
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7357-2
Online ISBN: 978-3-7091-6593-5
eBook Packages: Springer Book Archive